BPC157 (Bepecin, PL 14736), a small, chemically synthesised pentadecapeptide and a partial sequence of the human gastric juice protein BPC, which has been shown to be safe in clinical trials for inflammatory bowel disease and may be able to cure intestinal anastomosis dehiscence.
For GLP-1 comparison, read semaglutide vs tirzepatide
Your body loses its acclimation to the medication surprisingly quickly
We provide personalized education on dosage, timing, and proper injection technique, and we encourage you to reach out with any questions about your therapy
Additionally, BPC-157 promotes angiogenesis, or the development of new blood vessels, which is crucial for delivering nutrients and oxygen to damaged tissue